missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ Icatolimab Recombinant Monoclonal Antibody
GREENER_CHOICE

Recombinant Monoclonal Antibody

£397.00 - £1002.00

Specifications

Antigen Icatolimab Humanized
Concentration 1 mg/mL
Content And Storage -20°C, Avoid Freeze/Thaw Cycles
Applications ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance
Classification Recombinant Monoclonal
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
30283080
GREENER_CHOICE
View Documents
Invitrogen™
MA559403
100 μg
£397.00
100µg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
30282474
View Documents
Invitrogen™
MA559404
1 mg
£1002.00
1mg
Visualizzare prodotti alternativi
missing translation for 'toSaveUpto' 
»
Please to purchase this item. Need a web account? Register with us today!
Descrizione

Descrizione

For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °.

Icatolimab, also known as JS004 or TAB004, is a humanized IgG4 monoclonal antibody with a hinge mutation (S228P) that targets B and T Lymphocyte Attenuator (BTLA) and inhibits its interaction with its ligand, Herpesvirus Entry Mediator (HVEM). BTLA (B and T lymphocyte attenuator), also known as CD272, is a member of the CD28 immunoglobulin-superfamily of co-inhibitory receptors. It is located on chromosome 3q13.2 in humans. Structurally, BTLA is characterized by an extracellular immunoglobulin-like variable domain and intracellular immunoreceptor tyrosine-based inhibition motifs (ITIMs). Functionally, BTLA is predominantly expressed on CD4+ and CD8+ T cells, B cells, and various other immune cells. It serves as a negative regulator of immune responses by transmitting inhibitory signals upon interaction with its ligand, HVEM (herpesvirus entry mediator). These interactions are crucial in maintaining immune homeostasis and preventing autoimmunity. BTLA expression decreases upon T cell activation and is implicated in various immune disorders and cancer, where it modulates immune evasion mechanisms.
Specifica

Specifica

Icatolimab Humanized
-20°C, Avoid Freeze/Thaw Cycles
Recombinant Monoclonal
Lyophilized
IgG4SP
Human
Primary
Protein A
1 mg/mL
ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance
Unconjugated
Human
RUO
25mM histidine with 8% sucrose, 0.01% Tween 80 and no preservative; pH 6.2
Antibody
Videos
SDS
Documenti

Documenti

Certificati
Correzione del contenuto del prodotto

Fornite il vostro feedback sul contenuto del prodotto compilando il modulo sottostante.

Titolo del prodotto

Facendo clic su Invia, l'utente riconosce che potrebbe essere contattato da Fisher Scientific in merito al feedback fornito in questo modulo. Non condivideremo le vostre informazioni per altri scopi. Tutte le informazioni di contatto fornite saranno conservate in conformità con la nostra Politica sulla privacy. Informativa sulla privacy.

Grazie per averci aiutato a migliorare il nostro sito web. Il vostro feedback è stato inviato